Diffuse Large B Cell Lymphoma Clinical Trials in Shanghai
6 recruitingShanghai, China
Showing 1–6 of 6 trials
Recruiting
Phase 3
A Long-term Extension Study of PCI-32765 (Ibrutinib)
Diffuse Large B Cell LymphomaChronic Lymphocytic LeukemiaMantle Cell Lymphoma+4 more
Janssen Research & Development, LLC700 enrolled174 locationsNCT01804686
Recruiting
An Observational Study of Glofitamab in Chinese Adult Participants With 2L Diffuse Large B-Cell Lymphoma
Diffuse Large B Cell Lymphoma
Hoffmann-La Roche300 enrolled12 locationsNCT07200375
Recruiting
PET Imaging Targeting Granzyme B Predicts Immunotherapy Efficacy in Diffuse Large B-cell Lymphoma
Diffuse Large B Cell Lymphoma
Ruijin Hospital150 enrolled1 locationNCT06755775
Recruiting
Phase 2
Autologous Hematopoietic Stem Cell Boost Study After CAR-T Therapy
Diffuse Large B Cell Lymphoma
Ruijin Hospital18 enrolled1 locationNCT06589089
Recruiting
Phase 3
The Efficacy and Safety of Pola-ZR2 Versus ZR2 in the Treatment of Old Patients With de Novo Diffuse Large B-cell Lymphoma
Diffuse Large B Cell Lymphoma
Ruijin Hospital100 enrolled1 locationNCT06522555
Recruiting
Phase 1
An Open-label, Single-arm Study of JWCAR201 in the Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma
Diffuse Large B Cell Lymphoma
Fudan University9 enrolled1 locationNCT06517004